Rapid Micro Biosystems Announces Review of Strategic Alternatives to Maximize Shareholder Value
12 août 2022 07h00 HE
|
Rapid Micro Biosystems, Inc.
Rejects Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management Adopts Limited Duration Stockholder Rights Plan LOWELL, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro...
Rapid Micro Biosystems Provides Business Update and Reports Second Quarter 2022 Financial Results
12 août 2022 07h00 HE
|
Rapid Micro Biosystems, Inc.
Reports second quarter 2022 commercial revenue of $3.9 million Lowers full year 2022 commercial revenue guidance to at least $17.0 million Implements organizational restructuring plan to right-size...
Rapid Micro Biosystems to Announce Second Quarter 2022 Financial Results on August 12, 2022
09 août 2022 08h00 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Confirms Receipt of Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management
30 juin 2022 14h33 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports First Quarter 2022 Financial Results
10 mai 2022 06h00 HE
|
Rapid Micro Biosystems, Inc.
Reports first quarter 2022 commercial revenue of $4.2 million Reaffirms full year 2022 commercial revenue outlook range of $27 million to $32 million, representing growth of approximately 25% to...
Rapid Micro Biosystems to Announce First Quarter 2022 Financial Results on May 10, 2022
26 avr. 2022 16h10 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2021 Financial Results and Reaffirms Full Year 2022 Guidance
04 mars 2022 06h00 HE
|
Rapid Micro Biosystems, Inc.
Reports fourth quarter 2021 total revenue of $5.2 million and commercial revenue of $4.9 million Reports full year 2021 total revenue of $23.2 million and commercial revenue of $21.6 million ...
Rapid Micro Biosystems to Participate at the Cowen 42nd Annual Health Care Conference
23 févr. 2022 16h45 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2021 Financial Results on March 4, 2022
17 févr. 2022 16h10 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission...
Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications
20 janv. 2022 16h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...